|
flavivirus |
22 |
|
zika |
21 |
|
enterovirus |
20 |
|
antiviral |
19 |
|
adult |
18 |
|
covid-19 |
18 |
|
fatty acid |
16 |
|
lipidomics |
16 |
|
saliva |
16 |
|
uplc-esi-q-tof-ms |
16 |
|
interferon |
15 |
|
inhibitor |
14 |
|
coronavirus |
13 |
|
diagnosis |
13 |
|
treatment |
13 |
|
acute hepatitis |
12 |
|
aged |
12 |
|
bronchiectasis |
12 |
|
case report |
12 |
|
children |
12 |
|
chronic obstructive lung disease |
12 |
|
sars-cov-2 |
12 |
|
animal cell |
11 |
|
animal tissue |
11 |
|
bat |
11 |
|
coronavirus disease 2019 |
11 |
|
feces analysis |
11 |
|
viral load |
11 |
|
airborne infection |
10 |
|
diagnostics |
10 |
|
influenza virus |
10 |
|
animal |
9 |
|
bioaerosols |
9 |
|
genotype |
9 |
|
model |
9 |
|
mouse |
9 |
|
operating rooms |
9 |
|
orchitis |
9 |
|
pneumonia |
9 |
|
point-of-care testing |
9 |
|
steroid |
9 |
|
testis |
9 |
|
age |
8 |
|
amino acid sequence |
8 |
|
antibody blood level |
8 |
|
antibody response |
8 |
|
antibody titer |
8 |
|
asymptomatic |
8 |
|
asymptomatic infection |
8 |
|
case study |
8 |
|
conjunctiva |
8 |
|
coronavirus - classification - genetics - isolation & purification |
8 |
|
coronavirus infections - epidemiology - physiopathology - virology |
8 |
|
covid‐19 |
8 |
|
diagnostic |
8 |
|
diagnostic test evaluation |
8 |
|
hong kong |
8 |
|
human rhinovirus |
8 |
|
nanopore sequencing |
8 |
|
ns5 |
8 |
|
nsp1 |
8 |
|
real-time rt-pcr |
8 |
|
recombination |
8 |
|
recombination, genetic |
8 |
|
respiratory tract infections - epidemiology - physiopathology - virology |
8 |
|
reverse transcriptase polymerase chain reaction |
8 |
|
rt-pcr |
8 |
|
rt‐pcr |
8 |
|
sars‐cov‐2 |
8 |
|
seizures, febrile - epidemiology |
8 |
|
shedding |
8 |
|
acute disease |
7 |
|
bocavirus - classification - genetics - isolation & purification |
7 |
|
bromocriptine |
7 |
|
child |
7 |
|
child, preschool |
7 |
|
clade |
7 |
|
common cold - virology |
7 |
|
coronavirus infections - virology |
7 |
|
coronavirus oc43, human - classification - genetics - isolation and purification |
7 |
|
covid19 |
7 |
|
enterovirus d68 |
7 |
|
epidemiology |
7 |
|
epidemiology, molecular |
7 |
|
evaluation |
7 |
|
evolution, molecular |
7 |
|
fecal |
7 |
|
female |
7 |
|
gastroenteritis |
7 |
|
gastroenteritis - epidemiology - physiopathology - virology |
7 |
|
genome, viral |
7 |
|
human herpesvirus 6b |
7 |
|
humans |
7 |
|
immunological profiles |
7 |
|
infant |
7 |
|
infant, newborn |
7 |
|
lightmix e-gene |
7 |
|
male |
7 |
|
middle east respiratory syndrome |
7 |
|
molecular sequence data |
7 |
|
multigene family |
7 |
|
parvoviridae infections - epidemiology - physiopathology - virology |
7 |
|
phylodynamic |
7 |
|
phylogenetic |
7 |
|
phylogeny |
7 |
|
polymerase chain reaction |
7 |
|
protease |
7 |
|
respiratory tract infections - epidemiology - virology |
7 |
|
respiratory tract infections - virology |
7 |
|
rhinovirus - classification - genetics |
7 |
|
screening |
7 |
|
single-tube nested |
7 |
|
untranslated |
7 |
|
vaccine |
7 |
|
viral genome |
7 |
|
virus |
7 |
|
2019 novel coronavirus |
6 |
|
adenovirus |
6 |
|
air sampling |
6 |
|
ar-12 |
6 |
|
automated |
6 |
|
chemokine |
6 |
|
china - epidemiology |
6 |
|
coronavirus - genetics - isolation & purification |
6 |
|
coronavirus infections - genetics |
6 |
|
cost |
6 |
|
coxsackievirus a6 |
6 |
|
crossing over, genetic |
6 |
|
cytokine |
6 |
|
diagnostic assay |
6 |
|
disease outbreaks |
6 |
|
emerging |
6 |
|
enterovirus 71 |
6 |
|
enterovirus a, human - classification - genetics - isolation & purification |
6 |
|
envelope |
6 |
|
eosinophil |
6 |
|
feces - virology |
6 |
|
gastroenteritis - epidemiology - virology |
6 |
|
genes, viral/ - genetics |
6 |
|
genome subtraction |
6 |
|
genotyping |
6 |
|
hand, foot and mouth disease - epidemiology - virology |
6 |
|
hand-foot-and-mouth disease |
6 |
|
hepatitis c virus |
6 |
|
hepatitis e |
6 |
|
hev-c1 |
6 |
|
human adenovirus |
6 |
|
human rhinovirus c |
6 |
|
illumina sequencing |
6 |
|
immune response |
6 |
|
influenza |
6 |
|
intensive care unit |
6 |
|
intra-host diversity |
6 |
|
kinase |
6 |
|
molecular modelling |
6 |
|
multigene family - genetics |
6 |
|
nasopharyngeal |
6 |
|
nasopharyngeal swab |
6 |
|
neutralizing antibody |
6 |
|
next-generation sequencing |
6 |
|
novel |
6 |
|
novobiocin |
6 |
|
nsp2 |
6 |
|
outbreak |
6 |
|
pcr |
6 |
|
pediatric |
6 |
|
picornaviridae - classification - genetics - isolation and purification |
6 |
|
picornaviridae infections - epidemiology - virology |
6 |
|
pooling |
6 |
|
premembrane |
6 |
|
rat hepatitis e |
6 |
|
real-time pcr |
6 |
|
realstar® adenovirus pcr kit |
6 |
|
respiratory syncytial virus |
6 |
|
respiratory tract infection |
6 |
|
rhinovirus |
6 |
|
rhinovirus - classification - genetics - isolation and purification |
6 |
|
rna, viral - genetics |
6 |
|
seasonality |
6 |
|
seizure |
6 |
|
stool |
6 |
|
transmission |
6 |
|
viral hepatitis |
6 |
|
whole-genome sequencing |
6 |
|
zoonosis |
6 |
|
abbott real time hcv genotype ii |
5 |
|
adenosine deaminase |
5 |
|
aichi virus |
5 |
|
alere i flu a & b |
5 |
|
animals |
5 |
|
animals, domestic - virology |
5 |
|
bocavirus - classification - genetics - isolation and purification |
5 |
|
ccl22 |
5 |
|
cell line |
5 |
|
characterization |
5 |
|
chiroptera - virology |
5 |
|
contact examination |
5 |
|
controlled study |
5 |
|
coronaviridae - chemistry - classification - genetics - isolation and purification |
5 |
|
covid-19 severity |
5 |
|
diversity |
5 |
|
dromedary camel |
5 |
|
enterovirus - classification - genetics - isolation and purification |
5 |
|
epidemic |
5 |
|
genetic variation |
5 |
|
genogroup i |
5 |
|
hcov-229e |
5 |
|
hepatitis c |
5 |
|
herpes simplex virus 2 |
5 |
|
herpesviridae |
5 |
|
hong kong - epidemiology |
5 |
|
human alphaherpesvirus 1 |
5 |
|
human coronavirus |
5 |
|
human coronaviruses |
5 |
|
human parechovirus |
5 |
|
influenza a virus, h1n1 subtype - genetics - isolation & purification |
5 |
|
influenza, human - diagnosis - virology |
5 |
|
isolation |
5 |
|
luminex nxtag |
5 |
|
mammals |
5 |
|
mers |
5 |
|
middle east |
5 |
|
molecular epidemiology |
5 |
|
multiplex real time polymerase chain reaction |
5 |
|
myeloperoxidase |
5 |
|
nasopharyngeal specimen |
5 |
|
parvoviridae infections - veterinary - virology |
5 |
|
picobirnaviruses |
5 |
|
picornaviridae infections - veterinary - virology |
5 |
|
rabbits - virology |
5 |
|
rapid molecular test |
5 |
|
recombinant |
5 |
|
respiratory tract infections |
5 |
|
reverse transcriptase polymerase chain reaction - methods |
5 |
|
salivirus |
5 |
|
sea lion |
5 |
|
seasons |
5 |
|
sequence analysis, dna |
5 |
|
swine diseases - virology |
5 |
|
xpert xpress flu/rsv |
5 |
|
blood sampling |
4 |
|
capping phenomenon |
4 |
|
cat diseases - virology |
4 |
|
cats |
4 |
|
clinical laboratory |
4 |
|
detection |
4 |
|
disease surveillance |
4 |
|
disinfection |
4 |
|
dog diseases - virology |
4 |
|
epidemics |
4 |
|
foot and mouth disease |
4 |
|
genotype 6 |
4 |
|
hand |
4 |
|
hand foot and mouth disease |
4 |
|
hepatitis |
4 |
|
hku1 |
4 |
|
hrv-c |
4 |
|
human |
4 |
|
human hepegivirus 1 |
4 |
|
human herpesvirus 6 |
4 |
|
infection |
4 |
|
lineage |
4 |
|
new |
4 |
|
picornaviridae - chemistry - classification - genetics - isolation and purification |
4 |
|
proteinase k |
4 |
|
realstar® hhv-6 pcr kit |
4 |
|
respiratory |
4 |
|
species |
4 |
|
viral proteins - genetics |
4 |
|
aedes |
3 |
|
amino acid deletion |
3 |
|
arbovirus |
3 |
|
asthma |
3 |
|
immune |
3 |
|
influenza b |
3 |
|
microcephaly |
3 |
|
mosquito |
3 |
|
victoria lineage |
3 |
|
adenoviridae infections - epidemiology - veterinary - virology |
2 |
|
adenoviruses, human - genetics - isolation & purification |
2 |
|
adenoviruses, simian - genetics - isolation & purification |
2 |
|
ape diseases - epidemiology - virology |
2 |
|
bone marrow hypoplasia |
2 |
|
chronic lymphatic leukemia |
2 |
|
dna, viral - chemistry - isolation & purification |
2 |
|
molecular epidemiology. |
2 |
|
pan troglodytes |
2 |
|
respiratory infections. |
2 |
|
tanzania - epidemiology |
2 |
|
virus diseases - china - hong kong - epidemiology. |
2 |
|
viruses. |
2 |
